Energy deficit in Huntington disease

Why it matters

Fanny Mochel, Ronald G. Haller

Research output: Contribution to journalArticle

116 Citations (Scopus)

Abstract

Huntington disease (HD) is an autosomal dominant neurodegenerative disease with complete penetrance. Although the understanding of the cellular mechanisms that drive neurodegeneration in HD and account for the characteristic pattern of neuronal vulnerability is incomplete, defects in energy metabolism, particularly mitochondrial function, represent a common thread in studies of HD pathogenesis in humans and animal models. Here we review the clinical, biochemical, and molecular evidence of an energy deficit in HD and discuss the mechanisms underlying mitochondrial and related alterations.

Original languageEnglish (US)
Pages (from-to)493-499
Number of pages7
JournalJournal of Clinical Investigation
Volume121
Issue number2
DOIs
StatePublished - Feb 1 2011

Fingerprint

Huntington Disease
Penetrance
Neurodegenerative Diseases
Energy Metabolism
Animal Models

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Energy deficit in Huntington disease : Why it matters. / Mochel, Fanny; Haller, Ronald G.

In: Journal of Clinical Investigation, Vol. 121, No. 2, 01.02.2011, p. 493-499.

Research output: Contribution to journalArticle

@article{84056147b6f942eea65e98d3ce227ec2,
title = "Energy deficit in Huntington disease: Why it matters",
abstract = "Huntington disease (HD) is an autosomal dominant neurodegenerative disease with complete penetrance. Although the understanding of the cellular mechanisms that drive neurodegeneration in HD and account for the characteristic pattern of neuronal vulnerability is incomplete, defects in energy metabolism, particularly mitochondrial function, represent a common thread in studies of HD pathogenesis in humans and animal models. Here we review the clinical, biochemical, and molecular evidence of an energy deficit in HD and discuss the mechanisms underlying mitochondrial and related alterations.",
author = "Fanny Mochel and Haller, {Ronald G.}",
year = "2011",
month = "2",
day = "1",
doi = "10.1172/JCI45691",
language = "English (US)",
volume = "121",
pages = "493--499",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "2",

}

TY - JOUR

T1 - Energy deficit in Huntington disease

T2 - Why it matters

AU - Mochel, Fanny

AU - Haller, Ronald G.

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Huntington disease (HD) is an autosomal dominant neurodegenerative disease with complete penetrance. Although the understanding of the cellular mechanisms that drive neurodegeneration in HD and account for the characteristic pattern of neuronal vulnerability is incomplete, defects in energy metabolism, particularly mitochondrial function, represent a common thread in studies of HD pathogenesis in humans and animal models. Here we review the clinical, biochemical, and molecular evidence of an energy deficit in HD and discuss the mechanisms underlying mitochondrial and related alterations.

AB - Huntington disease (HD) is an autosomal dominant neurodegenerative disease with complete penetrance. Although the understanding of the cellular mechanisms that drive neurodegeneration in HD and account for the characteristic pattern of neuronal vulnerability is incomplete, defects in energy metabolism, particularly mitochondrial function, represent a common thread in studies of HD pathogenesis in humans and animal models. Here we review the clinical, biochemical, and molecular evidence of an energy deficit in HD and discuss the mechanisms underlying mitochondrial and related alterations.

UR - http://www.scopus.com/inward/record.url?scp=79551518229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551518229&partnerID=8YFLogxK

U2 - 10.1172/JCI45691

DO - 10.1172/JCI45691

M3 - Article

VL - 121

SP - 493

EP - 499

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 2

ER -